Efficacy and Safety of Rituximab in Hepatitis B Virus–Associated PLA2R-Positive Membranous Nephropathy

Lena Berchtold 1, 2 Gilbert Zanetta 3 Karine Dahan 4 Fabrice Mihout 4 Julie Peltier 5 Dominique Guerrot 6, 7 Isabelle Brocheriou 8 Pierre Ronco 1, 4, 2, * Hanna Debiec 1, 2
* Corresponding author
1 Des Maladies Rénales Rares aux Maladies Fréquentes, Remodelage et Réparation
2 Sorbonne Universités
3 Service de néphrologie (CHU de Dijon)
4 Service de Néphrologie et Dialyses [CHU Tenon]
5 Urgences néphrologiques et transplantation rénale [CHU Tenon]
6 Service de Néphrologie [Rouen]
7 CAPS - Cognition, Action, et Plasticité Sensorimotrice [Dijon - U1093]
8 Service de Pathologie [CHU Tenon]
Abstract : no abstract
Document type :
Journal articles
Complete list of metadatas

Cited literature [30 references]  Display  Hide  Download
https://www.hal.inserm.fr/inserm-02193809
Contributor : Pierre Ronco <>
Submitted on : Wednesday, July 24, 2019 - 5:43:45 PM
Last modification on : Wednesday, August 28, 2019 - 4:20:03 PM

File

KidneyIR2018.pdf
Publisher files allowed on an open archive

Identifiers

Collections

UNIV-BOURGOGNE | U1093 | COMUE-NORMANDIE | UNIROUEN | SORBONNE-UNIVERSITE | U1155 | SU-MEDECINE

Citation

Lena Berchtold, Gilbert Zanetta, Karine Dahan, Fabrice Mihout, Julie Peltier, et al.. Efficacy and Safety of Rituximab in Hepatitis B Virus–Associated PLA2R-Positive Membranous Nephropathy. Kidney International Reports, Elsevier, 2018, 3 (2), pp.486-491. ⟨10.1016/j.ekir.2017.09.009⟩. ⟨inserm-02193809⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

42

Files downloads

85

Contact

CCSD